CN Stock MarketDetailed Quotes

Chengdu Kanghua Biological Products (300841)

Watchlist
  • 57.08
  • -0.52-0.90%
Market Closed Apr 30 15:00 CST
7.42BMarket Cap32.75P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Chengdu Kanghua Biological Products (300841) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
非免疫规划疫苗1.16B99.99%
Other90.8K0.01%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Biological products1.16B99.99%
Other90.8K0.01%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
East China485.81M41.70%
Central China209.5M17.98%
South China144.86M12.43%
North China138.6M11.90%
Southwest110.22M9.46%
Northwest56.18M4.82%
Northeast China19.82M1.70%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +7.99%
Sample Name
Sample Code
 +4.00%
Sample Name
Sample Code
 +2.86%
4
SINOPEC CORP
00386
+2.22%
5
CNOOC
00883
+1.66%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +46.25%
Sample Name
Sample Code
 +33.47%
Sample Name
Sample Code
 +26.48%
4
Loongson Technology Corporation
688047
+24.63%
5
Rockchip Electronics
603893
+19.54%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Iran has announced its latest negotiation proposal: all issues should be resolved within 30 days, with the focus placed on 'ending the war' Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -